Literature DB >> 1278105

Influence of sodium intake on vascular and adrenal angiotensin II receptors.

G H Williams, N K Hollenberg, L M Braley.   

Abstract

The restriction of sodium intake reduces the sensitivity of vascular smooth muscle to angiotensin II, but enhances its influence on the adrenal glomerulosa cell. A competitive antagonist to angiotensin II, the Sar1, Ala8 derivative (P113), which shows affinity for the same receptor as angiotensin II, was used to examine the role of receptor affinity in the effect of sodium intake on these two systems in vitro. A threshold P113 concentration reduced the response to angiotensin of aortas derived from rabbits on a high, but not on a low, salt intake. Similarly, a threshold P113 concentration inhibited aldosterone response to angiotensin in glomerulosa cells obtained from sodium-loaded, but not sodium-restricted, rats. Large doses of P113 reduced the response to angiotensin in both preparations on either diet. The competitive antagonist presumably shares affinity for the same receptor on the basis of structural similarities; thus, the results suggest that sodium restriction blunts the vasoactive effects of angiotensin by reducing the affinity of its receptor for angiotensin. In contrast, the enhanced adrenal response to angiotensin with sodium restriction cannot be explained by an altered receptor-agonist interaction, but must reside in a change in an intracellular biochemical process, sufficient to overcome the influence of reduced receptor affinity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278105     DOI: 10.1210/endo-98-6-1343

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Control of aldosterone secretion during sodium restriction: adrenal receptor regulation and increased adrenal sensitivity to angiotensin II.

Authors:  G Aguilera; R L Hauger; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

2.  The adrenal receptor for angiotensin II is altered in essential hypertension.

Authors:  G H Williams; N K Hollenberg; T J Moore; S L Swartz; R G Dluhy
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

3.  Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

Review 4.  Aldosterone biosynthesis, regulation, and classical mechanism of action.

Authors:  Gordon H Williams
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

5.  The renin-aldosterone response to stimulation and suppression during normal pregnancy.

Authors:  Rhonda Bentley-Lewis; Steven W Graves; Ellen W Seely
Journal:  Hypertens Pregnancy       Date:  2005       Impact factor: 2.108

6.  Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice.

Authors:  Luminita H Pojoga; Tham M Yao; Sumi Sinha; Reagan L Ross; Jeffery C Lin; Joseph D Raffetto; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-04       Impact factor: 4.733

7.  Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.

Authors:  T Hata; T Ogihara; H Mikami; M Nakamaru; T Mandai; Y Kumahara
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

8.  Decreased adrenal responsiveness to angiotensin II: a defect present in spontaneously hypertensive rats. A possible model of human essential hypertension.

Authors:  G H Williams; L M Braley; A Menachery
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

9.  Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.

Authors:  D M Shoback; G H Williams; T J Moore; R G Dluhy; S Podolsky; N K Hollenberg
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.